Hybrid PET-CT Evaluation of Myocardial Viability

2021 ◽  
pp. 151-164
Author(s):  
Wail Nammas ◽  
Antti Saraste
Keyword(s):  
Myocardial Viability ◽  
Pet Ct ◽  
Ct Evaluation

FDG PET/CT Evaluation of Pediatric Patients With Yolk Sac Tumor

2019 ◽  
Vol 213 (3) ◽  
pp. 676-682 ◽  
Author(s):  
Wenfang Tang ◽  
Zihao Liu ◽  
Hongliang Fu ◽  
Chao Li ◽  
Hui Wang
Keyword(s):  
Fdg Pet ◽  
Pediatric Patients ◽  
Yolk Sac ◽  
Yolk Sac Tumor ◽  
Pet Ct ◽  
Ct Evaluation ◽  
Fdg Pet Ct

PET/CT Evaluation of Head and Neck Cancer of Unknown Primary

2019 ◽  
Vol 40 (5) ◽  
pp. 414-423 ◽  
Author(s):  
Megan Albertson ◽  
Srinivasa Chandra ◽  
Zafar Sayed ◽  
Craig Johnson
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Cancer Of Unknown Primary ◽  
Unknown Primary ◽  
Pet Ct ◽  
Ct Evaluation

scholarly journals Correlation between F18-FDG PET/CT Imaging and BRAF V600E Genetic Mutation for the Early Assessment of Treatment Response in Papillary Thyroid Cancers

2020 ◽  
Vol 10 (2) ◽  
pp. 52
Author(s):  
Andra Piciu ◽  
Maria-Iulia Larg ◽  
Doina Piciu
Keyword(s):  
Thyroid Cancer ◽  
Prognostic Factors ◽  
Papillary Thyroid Cancer ◽  
Genetic Mutation ◽  
Braf V600e Mutation ◽  
Braf V600e ◽  
Papillary Thyroid ◽  
Early Assessment ◽  
Pet Ct ◽  
Ct Evaluation

In thyroid neoplastic pathology, the BRAF V600E mutation is shown to be involved in the oncogenesis of papillary thyroid cancer and its subtypes. The purpose of this study is to evaluate the correlation between the mutation of the BRAF V600E oncogene and the pathological standardized uptake values (SUV) at the F18-fluorodeoxyglucose (F18-FDG) positron emission tomography/computed tomography (PET/CT) evaluation, for a group of 20 patients with radically treated (total thyroidectomy and radioiodine therapy) papillary thyroid cancer, with subclinical persistent disease, at 6 months after the initial treatment. We analyzed the correlations between the values of SUV and the presence of the BRAF mutation as well with other prognostic factors such as stage, age, specific tumor markers (thyroglobulin and anti-thyroglobulin), extrathyroid extension, the presence of metastatic lymph nodes or distant metastasis. The value of SUV in the case of BRAF+ (positive) patients was higher than in the negative ones, but without statistical significance, thus, the values of the SUV cannot be a predictable factor for the presence of the genetic mutation. There was a statistically significant correlation in BRAF+ subgroup between the SUV values and the positive resection limit following surgery, showing a higher SUV value in the PET/CT evaluation. No correlation was observed between the aforementioned prognostic factors involved in papillary thyroid cancer and the BRAF V600E mutation.

FDG PET-CT Evaluation of Granular Cell Tumor of the Soft Tissue

2010 ◽  
Vol 35 (3) ◽  
pp. 192-193 ◽  
Author(s):  
Kenichiro Hamada ◽  
Tetsuho Fujimoto ◽  
Shinsuke Omori ◽  
Makoto Emori ◽  
Susumu Joyama ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Fdg Pet ◽  
Granular Cell Tumor ◽  
Granular Cell ◽  
Cell Tumor ◽  
Pet Ct ◽  
Ct Evaluation ◽  
Fdg Pet Ct

Incidental finding of horseshoe kidneys in whole-body 18F-FDG PET/CT evaluation

2007 ◽  
Vol 26 (2) ◽  
pp. 105-106
Author(s):  
E. Roldán-Valadez ◽  
N. Ortega-López ◽  
I. Vega-González ◽  
G. Valdivieso-Cárdenas ◽  
A. Rumoroso-García ◽  
...  
Keyword(s):  
Fdg Pet ◽  
Incidental Finding ◽  
Whole Body ◽  
Pet Ct ◽  
Ct Evaluation ◽  
18F Fdg ◽  
Fdg Pet Ct
Sign in / Sign up

Export Citation Format

Share Document